New single-cell tool shows why antibody-based drugs fail The novel platform, called single-cell spatial pharmacobiology, revealed new insights into drug delivery of an antibody in Phase 1 trials. Written byAllison Whitten, PhD

https://www.drugdiscoverynews.com/new-single-cell-tool-shows-why-antibody-based-drugs-fail-17268 When a drug fails, it’s easy to assume that it was the wrong target or formulation or the side effects were too toxic. But it could also be that not enough of the drug got to its intended destination in the first place.